Non-familial systemic amyloidosis
Keywords:
systemic amyloidosis, potassium per manganate test, classification, diagnosis, clinical manifestationsAbstract
The authors present the causes of non familial systemic amyloidosis seen in a department of Internal Medicine. The work comprises 21 patients with a diagnosis of amyloidosis. The diagnostic distribution varied between primary (AL), secondary (AA) and b -microglobuün (b2m). The study group was comprised of 13 on women (62%) and 8 men (38%) with an average age of 61.5 years ( min. 31/max. 85).
ln this group the authors studied some aspects wich highlight the causes that lead to the investigation of amyloidosis, the associated pathologies, the clinical laboratorial syndromes the distribution of the several types of amyloidosis, the biopsy locations, the evolution of the diseases and the patients survivaL
Downloads
References
Robert C, Aractingi S, Prost C et al. Bullous amyloidosis - report of 3 cases and review of the literature. Medicine 1993; 72:38-44.
Husby G. Nomenclature and classification of amyloid and amyloidosis. J Intern Med 1992; 232:511-512.
Kyle RA. Amyloidosis. J lnt Med 1992; 232:507-508.
Kisilevsky. Proteoglycans, glycosaminoglicans, amyloid-enhancing factor, and amyloid deposition. J Int Med 1992; 232:515-516.
Pepys MB. Amyloid P component and the diagnosis of amyloidosis. J lnt Med 1992; 232:519-521.
Buxbaum J. Mechanisms of disease: monoclonal immunoglobulin deposition. Hematol Oncol Clin North Am 1992; 6:323-345.
Vogelgesang S, Klipple GL. The many guises of amyloidosis. Postgrad Med 1994; 96:119-127.
Wong CK, Wang WL. Systemic amyloidosis - a report of 19 cases. Dermatology 1994; 189:47-51
Gertz MA, Kyle RA. Secondary systemic amyloidosis: response and survival in 64 patients. Medicine 1991; 70:246-256.
Yakar S, Livneh A, Kaplan B, Pras M. The molecular basis of reactive amyloidosis. Semin Arthritis Rheum 1995; 24:255- 261
Lopes S, Costa A, Afonso A, Vedes J, Alexandrino B, Silva PS. Amiloidose AL ou AA - a propósito de um caso clínico. O Médico 1990; 123.165-166
Hawkins PN, Pepys MB. Amyloidosis. ln Malpas JS, Bergsagel DF, Kyle RA (eds.). Myeloma. Oxford: Oxford University Press. 1995:477-506.
Kyle RA, Gertz MA. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol 1995; 32:45-
Kyle RA. Primary systemic amyloidosis. J Int Med 1992; 232:523- 524.
Gabriel J, Pimenta P, Parente F et ai. Amiloidose sistémica e síndrome da veia cava superior em hemodialisado crónico. O Médico 1991; 125:386-390.
Kyle HA, Greipp PR, O'Fallon M. Primary systemic amyloidosis: multivariate analysis for prognostic factors in 168 cases. Blood 1986; 68:220-224.
Gouveia D, Carranca J, Lousada N et al. Amiloidose cardíaca: revisão da literatura. Rev Port Cardiol 1996; 15(2):657-664
Duston MA, Skinner M, Shirahama T, Cohen AS. Diagnosis of amyloidosis by abdominal fat aspiration. Am J Med 1987; 82:412-414.
Gertz MA, Kyle RA. Myopathy in primary systemic amyloidosis. J Neurol Neurosurg Psychiatry 1996; 60:655-660.
Glenner GG. Amyloid deposits and amyloidosis: the beta-fibrilloses. N Engl J Med 1980; 3021283-1292, 1333-134.3.
Cohen AS,Jones LA. Advances in amyloidosis. Curr Opin Rheu matol 1993; 5:62-76.
Gertz MA, Kyle RA. Amyloidosis: prognosis and treatment. Semin Arthritis Rheum 1994; 24:124-138.
Hawkins PN. Diagnosis and monitoring of amyloidosis. Baillie res Clin Rheumatol 1994; 8:635-659.
Maulin L, Hachulla E, Facon T et ai. Évaluation de l'amylose primitive (AL) par scintigraphie au composant sérique amylo'i de P: du diagnostic au prognostic. Rev Med Interne 1993; 14962.
Hachulla E, Deveaux M, Duquesnoy B, Marchandise X. Carto graphie de l'amylose par scintigraphie au composant sérique amyloide P marqué à !'iode 123: mythe ou réalité' Rev Med Interne 1994; 15:238-239
Hawkins PN, Richardson S, MacSweeney JE et al. Scintigraphic quantification and serial monitoring of human visceral amyloid
deposits provide evidence for turnover and regression. QJ Med 1993; 86:365-.174.
Hachulla E, Wechsler B, Deveaux M et al. Amylose localisée ou systémique? lntérêt et limites de la scintigraphie au composant amylo'ide P marqué à !'iode 123, place de la hiopsie de glandes salivaires accessoires. Rev Med Interne 1994; 15:182-185.
Hachulla E, Deveaux M, Duquesnoy B, Marchandise X. Scinti graphie au composant amylo'ide P marqué à !'iode 123: une nouvelle méthode d'évaluation de l'amylose. La Presse Médicale 1994; 23:348.
Stone MJ. Amyloidosis: a final common pathway for protein deposition in tissues. Blood 1990; 75:531-541
Additional Files
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 Medicina Interna